CG MedTech Co.,Ltd. (KOSDAQ:056090)

South Korea · Delayed Price · Currency is KRW

1,149.00

+6.00 (0.52%)

At close: Aug 11, 2026

11.12% (1Y)

Market Cap	118.03B +10.5%
Revenue (ttm)	48.51B +27.6%
Net Income	6.60B +337.1%
EPS	64.03 +222.0%
Shares Out	103.26M
PE Ratio	17.85
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	294,498
Open	1,124.00
Previous Close	1,143.00
Day's Range	1,103.00 - 1,157.00
52-Week Range	850.00 - 3,555.00
Beta	-0.13
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About CG MedTech

CG MedTech Co.,Ltd. researches, develops, manufactures, and sale of orthopedic medical devices in the healthcare service market. The company offers headless screws, cortex screws, and K-wires and pin; Aspiron and Maxima anterior cervical plate systems for use in anterior interbody screw/plate fixation of the cervical spine; ANAX OCT spinal system, a device for spinal surgery; Velofix PEEK SA cervical cages for cervical interbody fusion; and Velofix PEEK cage; and NeoIC PEEK cage, devices used with autograft or bone graft substitutes, as well as... [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies

Founded 1993

Employees 120

Stock Exchange KOSDAQ

Ticker Symbol 056090

Full Company Profile

Financial Performance

In 2025, CG MedTech's revenue was 47.23 billion, an increase of 36.43% compared to the previous year's 34.62 billion. Earnings were 6.51 billion, an increase of 10801.84%.

Financial Statements